WHO Expert Committee on Leprosy is constituted by

World Health Organization The World Health Organization (WHO) is a specialized agency of the United Nations responsible for international public health. The WHO Constitution states its main objective as "the attainment by all peoples of the highest possible level of h ...

to study the worldwide progress of

Leprosy Leprosy, also known as Hansen's disease (HD), is a long-term infection by the bacteria '' Mycobacterium leprae'' or '' Mycobacterium lepromatosis''. Infection can lead to damage of the nerves, respiratory tract, skin, and eyes. This nerve dam ...

Reports

* First report published as Technical Report Series No. 71 in 1954. * Second report published as Technical Report Series No. 189 in 1960. * Third report published as Technical Report Series No. 319 in 1966. * Fourth report published as Technical Report Series No. 459 in 1970. * Fifth report published as Technical Report Series No. 607 in 1977. * Sixth report published as Technical Report Series No. 768 in 1988. * Seventh report published as Technical Report Series No. 874 in 1998. They concluded that a single dose of a combination of

rifampicin Rifampicin, also known as rifampin, is an ansamycin antibiotic used to treat several types of bacterial infections, including tuberculosis (TB), ''Mycobacterium avium'' complex, leprosy, and Legionnaires’ disease. It is almost always used t ...

ofloxacin Ofloxacin is a quinolone antibiotic useful for the treatment of a number of bacterial infections. When taken by mouth or injection into a vein, these include pneumonia, cellulitis, urinary tract infections, prostatitis, plague, and certain types ...

and

minocycline Minocycline, sold under the brand name Minocin among others, is a tetracycline antibiotic medication used to treat a number of bacterial infections such as pneumonia. It is generally less preferred than the tetracycline doxycycline. It is also ...

is an acceptable and cost-effective alternative regimen for the treatment of single-lesion paucibacillary leprosy and the duration of the standard regimen for multibacillary leprosy could be shortened to 12 months. * Eighth report published as in 2012.

References

{{reflist World Health Organization Leprosy organizations